Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS)
CNY 26.29
(-0.6%)
CNY 26.29
(-0.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.65 Billion | 8.99 Billion | 7.63 Billion | 6.16 Billion | 6.93 Billion | 7.2 Billion |
| Cost of Revenue | 1.9 Billion | 1.53 Billion | 1.27 Billion | 1.13 Billion | 1.11 Billion | 1.09 Billion |
| Gross Profit | 7.74 Billion | 7.45 Billion | 6.35 Billion | 5.03 Billion | 5.82 Billion | 6.11 Billion |
| Operating Expenses | 4.61 Billion | 5.14 Billion | 4.66 Billion | 3.63 Billion | 4.01 Billion | 4.22 Billion |
| Selling, General and Administrative Expenses | 4.37 Billion | 4.2 Billion | 3.8 Billion | 3.09 Billion | 3.52 Billion | 3.74 Billion |
| Research and Development Expenses | 479.25 Million | 553.3 Million | 523.44 Million | 243.75 Million | 210.14 Million | 196.48 Million |
| Other Expenses | -243.11 Million | 392.75 Million | 339.95 Million | 294.48 Million | 279.63 Million | 75.35 Million |
| Cost and Expenses | 6.39 Billion | 6.68 Billion | 5.94 Billion | 4.76 Billion | 5.12 Billion | 5.31 Billion |
| Operating Income | 3.25 Billion | 2.42 Billion | 1.93 Billion | 1.46 Billion | 1.85 Billion | 1.9 Billion |
| Interest Expense | 18.59 Million | 30.4 Million | 34.89 Million | 33.02 Million | 30.73 Million | 34.14 Million |
| Income Tax Expense | 470.02 Million | 336.19 Million | 233.21 Million | 206.29 Million | 270.17 Million | 288.92 Million |
| Earnings before Tax | 3.29 Billion | 2.5 Billion | 1.95 Billion | 1.48 Billion | 1.89 Billion | 1.97 Billion |
| Net Income | 2.82 Billion | 2.17 Billion | 1.71 Billion | 1.27 Billion | 1.62 Billion | 1.68 Billion |
| Earnings Per Share Basic | 3.08 | 2.44 | 1.94 | 1.53 | 1.99 | 2.08 |
| Earnings Per Share Diluted | 3.08 | 2.39 | 1.91 | 1.53 | 1.99 | 2.07 |
| Weighted Average Shares Outstanding | 916.48 Million | 889.65 Million | 888.27 Million | 834.77 Million | 814.92 Million | 811.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 916.48 Million | 908.26 Million | 899.06 Million | 834.77 Million | 814.92 Million | 815.39 Million |
| Gross Margin | 0.80 | 0.83 | 0.83 | 0.82 | 0.84 | 0.85 |
| EBIT Margin | 0.37 | 0.32 | 0.30 | 0.29 | 0.31 | 0.30 |
| Profit Margin | 0.29 | 0.24 | 0.23 | 0.21 | 0.23 | 0.23 |
| EBITDA | 3.61 Billion | 2.85 Billion | 2.28 Billion | 1.8 Billion | 2.15 Billion | 2.18 Billion |
| Earnings Before Tax Margin | 0.34 | 0.27 | 0.25 | 0.24 | 0.27 | 0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.77 Billion | 1.6 Billion | 2.36 Billion | 9.5 Billion | 3.07 Billion | 1.9 Billion |
| Cost of Revenue | 380.13 Million | 398.9 Million | 453.69 Million | 1.9 Billion | 618.6 Million | 346.56 Million |
| Gross Profit | 1.39 Billion | 1.2 Billion | 1.91 Billion | 7.59 Billion | 2.45 Billion | 1.56 Billion |
| Operating Expenses | 807.45 Million | 775.38 Million | 1.15 Billion | 4.71 Billion | 1.51 Billion | 960.11 Million |
| Selling, General and Administrative Expenses | 947.51 Million | 691.47 Million | 1.03 Billion | - | 1.4 Billion | 951.6 Million |
| Research and Development Expenses | 88.65 Million | 83.91 Million | 114.22 Million | - | 117.41 Million | 119.53 Million |
| Other Expenses | -228.72 Million | 6 Million | 103.86 Million | 566.15 Thousand | 4.06 Million | -11.51 Million |
| Cost and Expenses | 1.18 Billion | 1.17 Billion | 1.6 Billion | 6.62 Billion | 2.13 Billion | 1.3 Billion |
| Operating Income | 661.86 Million | 432.71 Million | 755.98 Million | 2.88 Billion | 933.17 Million | 692.5 Million |
| Interest Expense | 6.86 Million | 8.32 Million | 7.55 Million | 17.58 Million | 7.59 Million | 3.43 Million |
| Income Tax Expense | 99.78 Million | 83.36 Million | 143 Million | 470.02 Million | 157.83 Million | 91.78 Million |
| Earnings before Tax | 665.83 Million | 577.86 Million | 989.79 Million | 3.29 Billion | 1.03 Billion | 697.1 Million |
| Net Income | 564.52 Million | 493.04 Million | 845.26 Million | 2.82 Billion | 878.62 Million | 604.31 Million |
| Earnings Per Share Basic | 0.62 | 1.10 | 0.92 | - | 0.96 | 0.66 |
| Earnings Per Share Diluted | 0.62 | 1.10 | 0.92 | - | 0.96 | 0.66 |
| Weighted Average Shares Outstanding | 916.22 Million | 916.44 Million | 916.44 Million | 916.44 Million | 916.44 Million | 915.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 916.22 Million | 916.77 Million | 916.77 Million | 916.44 Million | 916.44 Million | 918.41 Million |
| Gross Margin | 0.79 | 0.75 | 0.81 | 0.80 | 0.80 | 0.82 |
| EBIT Margin | 0.38 | 0.32 | 0.40 | - | 0.33 | 0.36 |
| Profit Margin | 0.32 | 0.31 | 0.36 | 0.30 | 0.29 | 0.32 |
| EBITDA | 672.7 Million | 508.92 Million | 939.63 Million | - | 1 Billion | 683.7 Million |
| Earnings Before Tax Margin | 0.37 | 0.27 | 0.32 | 0.30 | 0.30 | 0.36 |
TTE
HOYFF
SCC
ASTE
CMIL
HACBY